Public annual accounts

GLOBIPHARM financials

Name: GLOBIPHARM financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for GLOBIPHARM, with comparable measures and links to available source documents.

Company overview

Registry number

0843002254

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for GLOBIPHARM

2025 versus 2024

Operating line: €65,582
EBITDA: €60,173
Total assets: €540,740
Equity: €90,837

EBITDA margin +91.8% · Equity ratio +16.8%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€65,582	€60,173	€540,740	€90,837	-
202430 Sept 2024	€69,752	€64,770	€572,052	€74,437	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report